← All trials
NCT04951856
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 29, 2021
- Primary completion
- Sep 29, 2023
- Completion date
- Sep 29, 2023
- First posted
- Jul 7, 2021
- Last posted
- Oct 4, 2021
- Enrollment
- 1666
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Assistance Publique - Hôpitaux de ParisLead sponsor
- AmgenCollaborator
- Assistance Publique - Hôpitaux de ParisOverall official - principal investigator
- Action Research GroupCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.